CYTOSORBENTS CORPORATION (CTSO)

Import this data to Google Sheets with:

=jivedata("CTSO","financials")

Full statements spill as a table. For one cell: =jivedata("CTSO","Revenue") or =jivedata("CTSO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CYTOSORBENTS CORPORATION

CTSO • CIK 0001175151

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Including Assessed Tax	$36,349.379	$35,594.52	$37,063	$37,199.762
Cost of Goods and Services Sold	$13,957.356	$10,468.529	$10,572	$10,567
Gross Profit	$22,392.023	$25,125.991	$26,491	$26,649
Operating Income (Loss)	$-31,209.253	$-16,785.939	$-14,749	$-12,929
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-29,321.133	$-22,409.782	$-8,599	$-8,599
Income Tax Expense (Benefit)	$-813.739	$-1,690.825	$-401	$-401
Net Income (Loss) Attributable to Parent	$-28,507.394	$-20,718.957	$-8,198	$-18,214
Weighted Average Number of Shares Outstanding, Basic	44,656,391	54,434,609	62,231,771	63,329,085
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-30,307.268	$-16,691.953	$-15,427	$-15,250
Selling, General and Administrative Expense	$33,600.065	$34,995.749	$35,645	$34,119
Restructuring Charges	—	—	$510	$820
Operating Expenses	$53,601.276	$41,911.93	$41,240	$39,578
Interest Income (Expense), Nonoperating, Net	$-157.891	$-1,399.092	$-2,612	$-3,117
Foreign Currency Transaction Gain (Loss), before Tax	$1,949.257	$-4,224.721	$9,321	$-2,010
Nonoperating Income (Expense)	$1,888.12	$-5,623.843	$6,150	$-5,686
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$-1,799.874	$4,027.003	$-7,229	$2,964

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$14,131.137	$3,279.926	$6,249	$4,413
Restricted Cash, Current	—	$0.005	$5,000	$1,522
Property, Plant and Equipment, Net	$10,056.354	$9,002.383	$7,823	$7,172
Accounts Receivable, after Allowance for Credit Loss, Current	$6,057.072	$7,319.597	$7,550	$6,786
Restricted Cash, Noncurrent	$1,483.958	$1,483.958	$1,522	$1,522
Inventory, Net	$3,680.129	$2,732.907	$5,281	$3,686
Operating Lease, Right-of-Use Asset	$12,058.896	$11,511.236	$10,924	$10,612
Prepaid Expense and Other Assets, Current	$1,834.485	$3,270.812	$1,554	$852
Finite-Lived Intangible Assets, Net	$3,906.552	$3,748.036	$3,226	$2,864
Assets, Current	$25,702.823	$21,603.242	$20,634	$15,737
Other Assets, Noncurrent	$3,958.603	$3,770.681	$53	$53
Assets	$53,260.634	$47,371.5	$44,182	$37,960
Operating Lease, Liability, Noncurrent	$12,896.659	$12,443.971	$11,903	$11,596
Long-term Debt, Excluding Current Maturities	$2,542.857	$13,996.35	$16,667	$3,092
Liabilities	$29,985.471	$36,264.564	$38,279	$38,711
Accounts Payable, Current	$3,802.17	$3,339.885	$2,869	$2,002
Operating Lease, Liability, Current	$373.636	$452.688	$541	$589
Liabilities, Current	$14,545.955	$9,824.243	$9,709	$24,023
Common Stock, Value, Issued	$54.24	$54.83	$63	$63
Additional Paid in Capital	$305,196.874	$310,808.711	$321,024	$321,936
Accumulated Other Comprehensive Income (Loss), Net of Tax	$529.321	$4,252.013	$-2,977	$-996
Retained Earnings (Accumulated Deficit)	$-282,505.272	$-304,008.618	$-312,207	$-321,754
Stockholders' Equity Attributable to Parent	$23,275.163	$11,106.936	$5,903	$-751
Accounts Receivable, Allowance for Credit Loss, Current	$49.663	$157.701	$164	$421
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	54,240,265	54,830,146	62,804,305	62,842,748

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$-8,198	$-18,214
Net Cash Provided by (Used in) Operating Activities	$-21,655.136	$-14,427.809	$-12,377	$-9,147
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-99.769	$-84.676	$1,490	$1,153
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-8,216.931	$-5,851.211	$-1,993	$-5,791
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$15,615.095	$9,763.884	$7,771	$996.267
Payments to Acquire Property, Plant, and Equipment	$538.115	$284.343	$164	$150
Amortization of Debt Discount (Premium)	$564.356	$264.702	$820	$1,012
Proceeds from Sale of Property, Plant, and Equipment	—	—	$76	$76
Payments to Acquire Intangible Assets	$398.121	$385.087	$327	$286
Amortization of Intangible Assets	—	—	$262	$261
Net Cash Provided by (Used in) Investing Activities	$-936.236	$-669.43	$-415	$-275
Depreciation, Depletion and Amortization, Nonproduction	$1,462.436	$1,570.104	$1,234	$1,037
Inventory Write-down	—	—	$253	$253
Accounts Receivable, Credit Loss Expense (Reversal)	$14.434	$115.161	$40	$271
Tangible Asset Impairment Charges	—	—	$104	$104
Foreign Currency Transaction Gain (Loss), Unrealized	$1,949.256	$-4,224.721	$9,321	$-2,010
Share-based Payment Arrangement, Noncash Expense	$3,329.307	$3,759.534	$2,765	$2,286
Proceeds from Issuance of Long-term Debt	$5,000	$15,000	$2,478	$2,478
Repayments of Long-term Debt	—	$5,000	$5,000	$5,000
Payments of Loan Costs	—	$697.95	$698	$698
Proceeds from Warrant Exercises	—	—	$1,439	$1,439
Net Cash Provided by (Used in) Financing Activities	$14,474.21	$9,330.704	$9,309	$9,309
Interest Paid, Excluding Capitalized Interest, Operating Activities	$376.668	$1,290.396	$2,082	$2,279
Capital Expenditures Incurred but Not yet Paid	$359.965	$7.968	$8	$260.783
Stock Issued	$403.939	$197.892	$198	$200.025
Increase (Decrease) in Accounts Receivable	$245.616	$1,720.419	$-423	$-543
Increase (Decrease) in Inventories	$121.039	$-500.466	$2,540	$103
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,104.167	$1,351.805	$-1,791	$-539
Increase (Decrease) in Other Operating Assets	$0.05	$-1.05	$-2	$-2
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$1,623.58	$-1,807.575	$-706	$-33

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CTSO","financials")

Full statements spill as a table. For one cell: =jivedata("CTSO","Revenue") or =jivedata("CTSO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.